4.6 Article

Relationship of Arterial Stiffness Index and Pulse Pressure With Cardiovascular Disease and Mortality

Journal

Publisher

WILEY
DOI: 10.1161/JAHA.117.007621

Keywords

arterial stiffness; cardiovascular disease; cardiovascular outcomes; mortality; pulse pressure; UK Biobank

Funding

  1. Royal Netherlands Academy of Arts and Sciences' Van Walree grant
  2. Marie Sklodowska-Curie GF [661395]
  3. NWO VENI [016.186.125]
  4. Medical Research Council [MC_qA137853] Funding Source: researchfish

Ask authors/readers for more resources

Background-Vascular aging results in stiffer arteries and may have a role in the development of cardiovascular disease (CVD). Arterial stiffness index (ASI), measured by finger photoplethysmography, and pulse pressure (PP) are 2 independent vascular aging indices. We investigated whether ASI or PP predict new-onset CVD and mortality in a large community-based population. Methods and Results-We studied 169613 UK Biobank participants (mean age 56.8years; 45.8% males) who underwent ASI measurement and blood pressure measurement for PP calculation. MeanSD ASI was 9.30 +/- 3.1m/s and mean +/- SD PP was 50.98 +/- 13.2mmHg. During a median disease follow-up of 2.8years (interquartile range 1.4-4.0), 18190 participants developed CVD, of which 1587 myocardial infarction (MI), 4326 coronary heart disease, 1192 heart failure, and 1319 stroke. During a median mortality follow-up of 6.1years (interquartile range 5.8-6.3), 3678 participants died, of which 1180 of CVD. Higher ASI was associated with increased risk of overall CVD (unadjusted hazard ratio 1.27; 95% confidence interval [CI], 1.25-1.28), myocardial infarction (1.38; 95% CI, 1.32-1.44), coronary heart disease (1.31; 95% CI, 1.27-1.34), and heart failure (1.31; 95% CI 1.24-1.37). ASI also predicted mortality (all-cause, CVD, other). Higher PP was associated with overall CVD (1.57; 95% CI, 1.55-1.59), myocardial infarction (1.48; 95% CI, 1.42-1.54), coronary heart disease (1.47; 95% CI, 1.43-1.50), heart failure (1.47; 95% CI, 1.40-1.55), and CVD mortality (1.47; 95% CI, 1.40-1.55). PP improved risk reclassification of CVD in a non-laboratory-based Framingham Risk Score by 5.4%, ASI by 2.3%. Conclusions-ASI and PP are independent predictors of CVD and mortality outcomes. Although both improved risk prediction for new-onset disease, PP appears to have a larger clinical value than ASI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available